Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 8163642)

1.

The urokinase receptor is required for human monocyte chemotaxis in vitro.

Gyetko MR, Todd RF 3rd, Wilkinson CC, Sitrin RG.

J Clin Invest. 1994 Apr;93(4):1380-7.

2.

Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.

Yousif AM, Minopoli M, Bifulco K, Ingangi V, Di Carluccio G, Merlino F, Motti ML, Grieco P, Carriero MV.

PLoS One. 2015 May 4;10(5):e0126172. doi: 10.1371/journal.pone.0126172. eCollection 2015.

3.

Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.

Filaferro M, Novi C, Ruggieri V, Genedani S, Alboni S, Malagoli D, Caló G, Guerrini R, Vitale G.

Peptides. 2013 Jan;39:16-20. doi: 10.1016/j.peptides.2012.10.013. Epub 2012 Nov 8.

PMID:
23142110
4.

The urokinase-receptor in infectious diseases.

Montuori N, Selleri C, Ragno P.

Infez Med. 2012;20 Suppl 2:13-8. Review.

5.

Urokinase receptor surface expression regulates monocyte migration and is associated with accelerated atherosclerosis.

Chen W, Jin WQ, Chen LF, Williams T, Zhu WL, Fang Q.

Int J Cardiol. 2012 Nov 15;161(2):103-10. doi: 10.1016/j.ijcard.2011.12.094. Epub 2012 Jan 10.

PMID:
22236514
6.

Role(s) of formyl-peptide receptors expressed in nasal epithelial cells.

Prevete N, Salzano FA, Rossi FW, Rivellese F, Dellepiane M, Guastini L, Mora R, Marone G, Salami A, De Paulis A.

J Biol Regul Homeost Agents. 2011 Oct-Dec;25(4):553-64.

PMID:
22217988
7.

The urokinase system in the pathogenesis of atherosclerosis.

Fuhrman B.

Atherosclerosis. 2012 May;222(1):8-14. doi: 10.1016/j.atherosclerosis.2011.10.044. Epub 2011 Nov 16. Review.

PMID:
22137664
8.

Exposure to pesticides increases levels of uPA and uPAR in pre-malignant human prostate cells.

Potti A, Sehgal I.

Environ Toxicol Pharmacol. 2005 Feb;19(2):215-9. doi: 10.1016/j.etap.2004.04.010.

PMID:
21783479
9.

Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.

Pliyev BK, Antonova OA, Menshikov M.

Mol Immunol. 2011 May;48(9-10):1168-77. doi: 10.1016/j.molimm.2011.02.011. Epub 2011 Apr 5.

PMID:
21470685
10.

Chemotaxis of in vitro cultured human dendritic cells.

Luini W, D'Amico G, Bernasconi S, Allavena P, Mantovani A, Sozzani S.

Methods Mol Med. 2001;64:307-12. doi: 10.1385/1-59259-150-7:307.

PMID:
21374270
11.

Expression of urokinase plasminogen activator receptor on monocytes and granulocytes is modulated by cardiac surgery.

Krejsek J, Kolackova M, Kunes P, Jankovicova K, Mandak J, Andrys C.

Perfusion. 2011 Mar;26(2):115-21. doi: 10.1177/0267659110389845. Epub 2010 Nov 15.

PMID:
21078770
12.

Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.

Rasch MG, Pass J, Illemann M, Høyer-Hansen G, Lund IK.

J Immunol Methods. 2008 Nov 30;339(1):55-65. doi: 10.1016/j.jim.2008.08.002. Epub 2008 Aug 30.

PMID:
18761343
13.

Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection.

Gueler F, Rong S, Mengel M, Park JK, Kiyan J, Kirsch T, Dumler I, Haller H, Shushakova N.

J Immunol. 2008 Jul 15;181(2):1179-89.

14.

Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.

Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.

Stem Cells. 2008 Jun;26(6):1406-13. doi: 10.1634/stemcells.2008-0141. Epub 2008 Apr 10.

15.

The urokinase-system--role of cell proliferation and apoptosis.

Hildenbrand R, Gandhari M, Stroebel P, Marx A, Allgayer H, Arens N.

Histol Histopathol. 2008 Feb;23(2):227-36. Review.

PMID:
17999379
16.

Urokinase receptor variants in tissue and body fluids.

Høyer-Hansen G, Lund IK.

Adv Clin Chem. 2007;44:65-102. Review.

PMID:
17682340
17.

The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.

Salasznyk RM, Zappala M, Zheng M, Yu L, Wilkins-Port C, McKeown-Longo PJ.

Matrix Biol. 2007 Jun;26(5):359-70. Epub 2007 Feb 6.

PMID:
17344041
18.

Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.

Shanmukhappa K, Sabla GE, Degen JL, Bezerra JA.

BMC Gastroenterol. 2006 Nov 29;6:40.

19.

Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.

Franco P, Vocca I, Carriero MV, Alfano D, Cito L, Longanesi-Cattani I, Grieco P, Ossowski L, Stoppelli MP.

J Cell Sci. 2006 Aug 15;119(Pt 16):3424-34. Epub 2006 Aug 1.

20.

Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.

Yin S, Lockett J, Meng Y, Biliran H Jr, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S.

Cancer Res. 2006 Apr 15;66(8):4173-81.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk